Molecular mechanisms of bacterial virulence: type III secretion and pathogenicity islands

Emerging Infectious Diseases
J J Mecsas, E J Strauss

Abstract

Recently, two novel but widespread themes have emerged in the field of bacterial virulence: type III secretion systems and pathogenicity islands. Type III secretion systems, which are found in various gram-negative organisms, are specialized for the export of virulence factors delivered directly to host cells. These factors subvert normal host cell functions in ways that seem beneficial to invading bacteria. The genes encoding several type III secretion systems reside on pathogenicity islands, which are inserted DNA segments within the chromosome that confer upon the host bacterium a variety of virulence traits, such as the ability to acquire iron and to adhere to or enter host cells. Many of these segments of DNA appear to have been acquired in a single step from a foreign source. The ability to obtain complex virulence traits in one genetic event, rather than by undergoing natural selection for many generations, provides a mechanism for sudden radical changes in bacterial-host interactions. Type III secretion systems and pathogenicity islands must have played critical roles in the evolution of known pathogens and are likely to lead to the emergence of novel infectious diseases in the future.

References

Apr 1, 1990·Molecular Microbiology·R RosqvistH Wolf-Watz
Sep 1, 1987·Reviews of Infectious Diseases·S FalkowD Corwin
Aug 1, 1995·Current Opinion in Immunology·B JonesS Falkow
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·J LiR K Selander
Jul 1, 1995·Canadian Journal of Microbiology·H Ochman, E A Groisman
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·K G JarvisJ B Kaper
Jan 1, 1995·Journal of Medical Microbiology·S PajniS Roychowdhury
May 23, 1995·Proceedings of the National Academy of Sciences of the United States of America·M WataraiC Sasakawa
Feb 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·T K McDanielJ B Kaper
May 28, 1994·Lancet·M K Waldor, J J Mekalanos
Jan 1, 1993·Trends in Biochemical Sciences·G P Salmond, P J Reeves
Aug 1, 1995·Trends in Microbiology·S C Straley, R D Perry
Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·R MénardC Dehio
Mar 19, 1996·Proceedings of the National Academy of Sciences of the United States of America·J E SheaD W Holden
Jun 28, 1996·Science·M K Waldor, J J Mekalanos
Apr 1, 1996·Molecular Microbiology·P WattiauG R Cornelis
Apr 1, 1996·Molecular Microbiology·J E Galán
Jun 1, 1996·Trends in Microbiology·R MénardP J Sansonetti
Jun 1, 1996·Trends in Microbiology·R M Harshey, A Toguchi
Aug 1, 1996·Current Biology : CB·C Stephens, L Shapiro
Feb 1, 1996·Trends in Microbiology·I MaticM Radman
Jan 1, 1996·Molecular Microbiology·S I Aizawa

❮ Previous
Next ❯

Citations

Apr 6, 2004·Biotechnology Advances·David S Guttman
Oct 12, 2001·Toxicon : Official Journal of the International Society on Toxinology·C L Sears
Oct 11, 2003·Biotechnology Advances·J W Chan, P H Goodwin
Mar 12, 2003·Molecular and Cellular Probes·Katja StuberPeter Kuhnert
Oct 12, 2000·Current Opinion in Biotechnology·D E Lehoux, R C Levesque
Mar 6, 1999·Current Opinion in Microbiology·D A Relman, A Wright
Aug 5, 1998·Proceedings of the National Academy of Sciences of the United States of America·J G Lawrence, H Ochman
Jan 6, 2001·The Pediatric Infectious Disease Journal·S M GrahamC A Hart
Sep 9, 2010·Acta Crystallographica. Section F, Structural Biology and Crystallization Communications·M PalJ B Cooper
Nov 22, 2001·Journal of Bacteriology·M BraunsteinW R Jacobs
Sep 7, 2000·Microbiology and Molecular Biology Reviews : MMBR·S S Hirano, C D Upper
Apr 30, 2009·Annual Review of Phytopathology·Isaac Barash, Shulamit Manulis-Sasson
May 26, 1999·Emerging Infectious Diseases·T M WizemannS Langermann
Jul 8, 1997·Proceedings of the National Academy of Sciences of the United States of America·E D SegalS Falkow
Apr 20, 2001·Critical Reviews in Biotechnology·S ParkR A Durst
Apr 20, 2001·International Journal of Medical Microbiology : IJMM·A FauconnierE Godfroid
Nov 21, 2007·Trends in Microbiology·Isaac Barash, Shulamit Manulis-Sasson
May 8, 2007·Trends in Microbiology·Jan PetersPatrik M Bavoil
Apr 17, 2007·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Elias HakalehtoAnneli Heitto
Sep 1, 2003·Molecular Plant Pathology·Shulamit Manulis, Isaac Barash

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.